Aqua Bio Technology ASA (ABT.OL)

NOK 6.93

(0.0%)

Total Liabilities Summary of Aqua Bio Technology ASA

Aqua Bio Technology ASA's latest annual total liabilities in 2021 was 15.72 Million NOK , up 98.6% from previous year.
Aqua Bio Technology ASA's latest quarterly total liabilities in 2022 Q2 was 13.49 Million NOK , down 0.0% from previous quarter.
Aqua Bio Technology ASA reported annual total liabilities of 7.91 Million NOK in 2020, up 158.45% from previous year.
Aqua Bio Technology ASA reported annual total liabilities of 3.06 Million NOK in 2019, down -69.77% from previous year.
Aqua Bio Technology ASA reported quarterly total liabilities of 14.3 Million NOK for 2021 Q2, down 0.0% from previous quarter.
Aqua Bio Technology ASA reported quarterly total liabilities of 15.72 Million NOK for 2021 FY, up 98.6% from previous quarter.

Annual Total Liabilities Chart of Aqua Bio Technology ASA (2021 - 2008)

Historical Annual Total Liabilities of Aqua Bio Technology ASA (2021 - 2008)

Year	Total Liabilities	Total Liabilities Growth
2021	15.72 Million NOK	98.6%
2020	7.91 Million NOK	158.45%
2019	3.06 Million NOK	-69.77%
2018	10.13 Million NOK	-4.05%
2017	10.56 Million NOK	9.43%
2016	9.65 Million NOK	3.31%
2015	9.34 Million NOK	-1.07%
2014	9.44 Million NOK	-23.47%
2013	12.33 Million NOK	-23.71%
2012	16.17 Million NOK	-1.72%
2011	16.45 Million NOK	58.74%
2010	10.36 Million NOK	2.72%
2009	10.09 Million NOK	-28.23%
2008	14.06 Million NOK	0.0%

Year	Total Liabilities	Total Liabilities Growth
2022 Q2	13.49 Million NOK	0.0%
2021 Q2	14.3 Million NOK	0.0%
2021 FY	15.72 Million NOK	98.6%
2021 Q4	15.72 Million NOK	0.0%
2020 FY	7.91 Million NOK	158.45%
2020 Q4	7.91 Million NOK	0.0%
2020 Q2	3.13 Million NOK	0.0%
2019 Q2	9.16 Million NOK	0.0%
2019 Q4	3.06 Million NOK	0.0%
2019 FY	3.06 Million NOK	-69.77%
2018 Q2	9.35 Million NOK	0.0%
2018 Q4	10.13 Million NOK	0.0%
2018 FY	10.13 Million NOK	-4.05%
2017 Q2	7.7 Million NOK	0.0%
2017 FY	10.56 Million NOK	9.43%
2017 Q4	10.56 Million NOK	0.0%
2016 Q2	16.33 Million NOK	43.59%
2016 Q1	11.37 Million NOK	21.79%
2016 Q4	9.65 Million NOK	14.77%
2016 FY	9.65 Million NOK	3.31%
2016 Q3	8.4 Million NOK	-48.53%
2015 Q3	8.83 Million NOK	-4.96%
2015 FY	9.34 Million NOK	-1.07%
2015 Q2	9.3 Million NOK	14.79%
2015 Q1	8.1 Million NOK	-14.19%
2015 Q4	9.34 Million NOK	5.68%
2014 FY	9.44 Million NOK	-23.47%
2014 Q4	9.44 Million NOK	6.82%
2014 Q3	8.83 Million NOK	-29.43%
2014 Q2	12.52 Million NOK	10.85%
2014 Q1	11.29 Million NOK	-8.42%
2013 Q3	11.18 Million NOK	-14.86%
2013 FY	12.33 Million NOK	-23.71%
2013 Q4	12.33 Million NOK	10.28%
2013 Q1	12.29 Million NOK	-24.01%
2013 Q2	13.14 Million NOK	6.91%
2012 FY	16.17 Million NOK	-1.72%
2012 Q4	16.17 Million NOK	-4.55%
2012 Q3	16.94 Million NOK	-13.4%
2012 Q2	19.56 Million NOK	28.39%
2012 Q1	15.23 Million NOK	-7.4%
2011 FY	16.45 Million NOK	58.74%
2011 Q2	9.48 Million NOK	6.13%
2011 Q4	16.45 Million NOK	102.04%
2011 Q3	8.14 Million NOK	-14.14%
2011 Q1	8.93 Million NOK	-13.77%
2010 FY	10.36 Million NOK	2.72%
2010 Q4	10.36 Million NOK	0.0%
2009 FY	10.09 Million NOK	-28.23%
2008 FY	14.06 Million NOK	0.0%

Peer Total Liabilities Comparison of Aqua Bio Technology ASA

Name	Total Liabilities	Total Liabilities Difference
Arctic Bioscience AS	41.69 Million NOK	62.29%
ArcticZymes Technologies ASA	30.02 Million NOK	47.635%
BerGenBio ASA	46.85 Million NOK	66.446%
Hofseth BioCare ASA	348.97 Million NOK	95.495%
PCI Biotech Holding ASA	5 Million NOK	-213.959%
Thor Medical ASA	58.91 Million NOK	73.31%
Ultimovacs ASA	69.64 Million NOK	77.425%